Option Care Health (OPCH) Projected to Post Earnings on Wednesday

Option Care Health (NASDAQ:OPCH) is projected to release its earnings data before the market opens on Wednesday, February 26th. Analysts expect Option Care Health to post earnings of $0.33 per share and revenue of $1.29 billion for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Option Care Health Stock Up 2.0 %

OPCH stock opened at $32.09 on Wednesday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company’s 50 day moving average is $27.19 and its 200 day moving average is $27.91. The stock has a market cap of $5.46 billion, a price-to-earnings ratio of 26.97, a price-to-earnings-growth ratio of 2.19 and a beta of 1.35. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.63.

Wall Street Analysts Forecast Growth

OPCH has been the topic of a number of recent research reports. JMP Securities reiterated a “market outperform” rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. JPMorgan Chase & Co. raised their target price on shares of Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Barrington Research raised their target price on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. Truist Financial cut their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Finally, Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $32.25.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.